25 Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Clean Energy Fuels Corp CLNE rose 34.7 percent to $3.30 in pre-market trading after BP plc (ADR) BP agreed to pay $155 million for Clean Energy's existing biomethane production facilities.
• Dynavax Technologies Corporation DVAX shares rose 28.9 percent to $5.80 in pre-market trading after the company reported the FDA acceptance for review of its November's HEPLISAV-B CRL.
• Neuroderm Ltd NDRM rose 16.6 percent to $27.00 in pre-market trading after the company disclosed that it has achieved primary endpoint in ND0612H Phase 2 trial for advanced Parkinson's disease.
• Big 5 Sporting Goods Corporation BGFV rose 15.2 percent to $15.50 in pre-market trading after the company reported upbeat Q4 earnings and issued a strong forecast.
• Weight Watchers International, Inc. WTW shares rose 12.6 percent to $16.20 in pre-market trading as the company posted stronger-than-expected results for its fourth quarter on Tuesday.
• PDL BioPharma Inc PDLI rose 12.2 percent to $2.40 in pre-market trading. PDL BioPharma reported a $30 million buyback plan.
• Liquidity Services, Inc. LQDT rose 11 percent to $9.05 in pre-market trading after dropping 0.61 percent on Tuesday.
• Tribune Media Co TRCO rose 9.5 percent to $37.80 in pre-market trading. Tribune Media reported Q4 earnings of $0.22 per share on sales of $529.6 million, and announced a $400 million buyback plan.
• Calithera Biosciences Inc CALA shares rose 8.3 percent to $9.75 in pre-market trading after dropping 0.55 percent on Tuesday.
• PhotoMedex Inc PHMD shares rose 7.8 percent to $2.35 in pre-market trading after dropping 6.03 percent on Tuesday.
• Lowe's Companies, Inc. LOW rose 7.4 percent to $79.88 in pre-market trading as the company reported upbeat results for its fourth quarter and issued strong sales outlook for 2017.
• NRG Energy Inc NRG rose 7.2 percent to $17.75 in pre-market trading after the company reported 2016 results.
• Corecivic Inc CXW rose 7 percent to $36.07 in pre-market trading after dropping 2.21 percent on Tuesday.
• Lexicon Pharmaceuticals, Inc. LXRX shares rose 6 percent to $17.00 in pre-market trading after the company reported the FDA approval of lexicon drug XERMELO.
• Amicus Therapeutics, Inc. FOLD shares rose 4.8 percent to $6.80 in pre-market trading. Amicus reported a FY16 loss of $1.49 per share on revenue of $4.958 million.
• Dollar Tree, Inc. DLTR rose 4.2 percent to $79.90 in pre-market trading after reporting upbeat quarterly results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Impax Laboratories Inc IPXL shares fell 22.5 percent to $11.05 in the pre-market trading session. Impax Labs reported Q4 adjusted earnings of $0.16 per share on revenue of $198.4 million.
• Palo Alto Networks Inc PANW fell 18.5 percent to $123.78 in pre-market trading. Palo Alto posted upbeat Q2 earnings, but sales missed expectations. The company also issued a weak forecast for the current quarter.
• Best Buy Co Inc BBY dropped 9.4 percent to $40.00 in pre-market trading. Best Buy reported better-than-expected earnings for its fourth quarter, but sales missed estimates. The company also issued weak earnings forecast for the current quarter.
• Sarepta Therapeutics Inc SRPT shares fell 7.6 percent to $28.75 in pre-market trading despite posting a smaller loss than analysts predicted and topping sales estimates.
• Build-A-Bear Workshop, Inc BBW fell 5.5 percent to $8.55 in pre-market trading after declining 2.16 percent on Tuesday.
• Enphase Energy Inc ENPH shares fell 5.1 percent to $1.70 in pre-market trading as the company posted weak Q4 results.
• Etsy Inc ETSY fell 5.1 percent to $11.51 in pre-market trading. Etsy reported a Q4 GAAP loss of $0.16 per share.
• Ambarella Inc AMBA shares fell 4.1 percent to $56.57 in pre-market trading. Ambarella reported upbeat results for its fourth quarter, but issued a weak sales forecast for the current quarter.
• salesforce.com, inc. CRM fell 2.2 percent to $79.60 in pre-market trading. salesforce.com reported better-than-expected results for its fourth quarter, but issued a weak outlook for the current quarter.